Marshall Bursis 1/30/24 Marshall Bursis 1/30/24

Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model

Marshall Bursis 9/25/23 Marshall Bursis 9/25/23

Statement / Background Info Regarding the Institute for Clinical and Economic Review’s (ICER) Proposed Value Assessment Framework

Marshall Bursis 9/6/23 Marshall Bursis 9/6/23

Marshall Bursis 6/30/23 Marshall Bursis 6/30/23

Marshall Bursis 12/8/22 Marshall Bursis 12/8/22

Marshall Bursis 8/18/22 Marshall Bursis 8/18/22

Insurance Reform Needed to Cover Prescribed Medicines without High Out-of-Pocket Costs

Marshall Bursis 7/25/22 Marshall Bursis 7/25/22

Marshall Bursis 1/10/22 Marshall Bursis 1/10/22

“If a doctor prescribes a treatment and the insurer authorizes it, the copay should be affordable.”

Marshall Bursis 4/30/21 Marshall Bursis 4/30/21

Marshall Bursis 4/28/21 Marshall Bursis 4/28/21

Marshall Bursis 3/11/21 Marshall Bursis 3/11/21

BECOME A FIRST RESPONDER & THOUGHT PARTNER

Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.